Healthcare Compliance Due Diligence: What Buyers Test and How to Prepare
Healthcare buyers test six things before they price a practice. They check whether the charts support the codes billed and whether payer contracts and provider credentialing survive the sale. They map how every physician is paid and connected to referrals. They also look at how mature the compliance program is, what prior audits and refunds show, and how patient data is protected. Findings rarely kill a deal. They move money. Overbilled revenue comes out of EBITDA and off the price at the multiple. Historical exposure goes into a special escrow or a specific indemnity, because reps and warranties insurance generally excludes issues the buyer already knows about. A seller who runs the same tests 12 to 18 months before going to market controls the numbers, the story and the timing.
Data as of November 20, 2026. Market figures are linked to their sources where they appear, the worked example uses labeled assumptions rather than market figures, and the sources are listed at the end.
The Six Workstreams in Healthcare Compliance Diligence
| Workstream | What the buyer tests | Evidence it requests | Where a finding lands in the deal |
|---|---|---|---|
| Billing and coding audit | Do chart notes support the codes, modifiers and units billed? Does any provider code far above peers? | Claims data by provider and code, a random chart sample, prior internal and external audits | EBITDA normalization, price cut at the multiple, refund holdback |
| Payer contracts and credentialing | Do contracts survive a change of control? Is every provider enrolled and credentialed with every payer billed under their name? | Every payer contract and amendment, credentialing roster, Medicare and Medicaid enrollment records | Closing conditions, consent deliverables, working capital adjustment for delayed collections |
| Physician compensation and referral map | How is each physician paid, what does each one own, and who refers to whom? | Employment and pay agreements, bonus calculations, leases, directorships, ownership questionnaires | Rewritten pay plans and earnout metrics, specific indemnity |
| Compliance program maturity | Does a working program exist, and does anyone test it? | Compliance plan, training logs, hotline log, exclusion screening log, audit calendar | Wider buyer sampling, pre-closing covenants, a lower multiple for weak controls |
| Prior audits, refunds and overpayments | What have payers already found, and what is still open? | Audit letters, recoupment notices, refund log, credit balance report | Special escrow, specific indemnity, exclusion from insurance |
| Privacy and data security | Has patient data been breached, and are controls current? | Privacy and security risk assessment, policies, business associate agreements, breach log | Remediation covenant, cyber insurance requirement, specific indemnity |
The first three workstreams mostly change the earnings a buyer will capitalize. The last three mostly change how hard the buyer looks and how much of the price it holds back.
Why Every Add-On Repeats the Screen
Most healthcare deals are add-ons, and each one goes through the same compliance screen before the platform absorbs it. A platform that has done several acquisitions often has a well-developed request list, and a seller should expect it early in the process.
| PE-backed healthcare deals, calendar 2025 (PESP, Private Equity Healthcare Deals: 2025 in Review) | Count |
|---|---|
| Total PE-backed deals tracked | 1,029 |
| Add-on acquisitions | 664 |
| Growth investments | 214 |
| Leveraged buyouts | 151 |
| Platform companies involved | 420 |
| Investment firms involved | 708 |
PESP built its count from PitchBook and LevinPro HC data and says the final count is likely an underestimate. These are one tracker's counts, not official totals, so read them as directional.
| Busiest subsectors in PESP's 2025 in Review report (directional, likely undercounts) | PE deals | Where compliance diligence concentrates (our read) |
|---|---|---|
| Health IT | 151 | Privacy and security controls, data rights, referral-linked fees |
| Dental care | 149 | Medicaid billing, coding of periodontal and restorative procedures, credentialing at each site |
| Outpatient care | 148 | Ancillary billing, physician leases, credentialing of new providers |
| Medtech | 117 | Physician consulting and royalty payments |
| Behavioral health | 56 | Payer audits of time-based codes, facility licensing, patient recruiting fees, privacy |
Dental shows the pattern most clearly. PESP reports that 95% of the 149 dental deals it tracked in 2025 were add-ons by PE-owned platforms, and that 10 of the 18 platforms with the most deals were dental companies. These are directional figures from one tracker and may be undercounts. In outpatient care, Becker's ASC Review, reporting PESP's 2025 data, counted 119 add-ons among 148 deals. Dermatology led with 24, followed by eye care at 22 and oncology at 9.
Billing and Coding Audit: How Buyers Test the Revenue
A buyer's coding team pulls claims data, draws a sample, compares each claim to the chart note and turns the result into dollars. Two rates come out of that work, and only one of them moves price.
| Metric | How it is calculated | What it tells the buyer |
|---|---|---|
| Claim error rate | Claims with any coding error ÷ claims sampled | How often documentation fails |
| Dollar error rate | Overpaid dollars ÷ paid dollars in the sample | How much revenue is overstated. This is the rate that moves price |
| Direction of error | Overcoded claims vs undercoded claims | Whether errors lean one way. Buyers generally model overpayments gross, because refunds run one way |
| Provider distribution | Each provider's share of top-level visits vs peers seeing similar patients | Where to expand the sample |
| Error type | Level of service, modifiers, units on timed codes, place of service, supervision and telehealth billing | Whether the cause is training, a template or one person |
An outlier provider is a reason to look further, not proof of overcoding. Some physicians see sicker patients. The chart notes settle it.
Where coding findings cluster.
| Setting | Items buyers sample first |
|---|---|
| Physician practices | Distribution of office visit levels by provider, modifier use on same-day procedures, services billed under a supervising physician |
| Dental | Periodontal procedures billed in place of routine cleanings, build-ups and crowns, Medicaid claims by site |
| Physical therapy and behavioral health | Units on timed codes, group vs individual session billing, documentation of session length |
| ASCs | Implant and supply billing, procedure modifiers, payer-specific carve-outs |
| Telehealth-heavy models | Place of service, provider location and licensure, documentation of visit type |
Pre-market coding sample (our recommended method).
- Pull 12 months of claims and rank codes by paid dollars, not by volume.
- Draw a random sample for each high-dollar code, with enough claims per provider to compare providers.
- Have a certified coder who does not work for the practice compare each claim to the chart.
- Calculate both the claim error rate and the dollar error rate, by provider and by code.
- Expand the sample wherever errors cluster.
- Fix the cause, retrain, then re-sample a quarter later so the data room shows the trend improving.
- Quantify the refunds owed and decide how to resolve them before marketing.
Our quality of earnings prep checklist shows how coding findings flow into adjusted EBITDA.
Exclusion screening. Check every physician, clinician and employee against the HHS OIG exclusion list and keep a dated log. An excluded individual on payroll is a serious finding. Depending on the facts, the claims involved and the deal terms, buyers often require it to be resolved before closing and look for claims tied to that person.
Payer Contracts and Credentialing Review
Payer mix sets how much audit and recoupment risk a buyer is underwriting. Both government and commercial payers audit and recoup. Per the CMS National Health Expenditure fact sheet, which reports 2024 data, Medicare spending grew 7.8% to $1,118.0 billion in 2024, 21% of national health spending. Private health insurance spending was $1,644.6 billion, 31%. Buyers also reward commercial concentration. FOCUS Investment Banking's 2026 dermatology valuation benchmarks say that, in the firm's view, buyers prize practices with more than 70% commercial or cash-pay revenue, citing faster collections and protection from government reimbursement cuts.
What buyers read in every payer contract.
| Clause | What the buyer checks | Deal consequence |
|---|---|---|
| Assignment and change of control | Does the sale need the payer's consent, or let the payer terminate? | Consent becomes a closing deliverable. A missing consent puts that revenue at risk |
| Term and termination without cause | How quickly can the payer exit? | Short notice periods on a large payer weaken revenue quality |
| Rate schedule and escalators | Are rates fixed, tied to a fee schedule or renegotiable? | Sets the revenue the buyer will model after closing |
| Recoupment and offset rights | Can the payer claw back overpayments from future payments? | A pending recoupment reduces post-closing cash |
| Audit rights and look-back | How far back can the payer audit? | Sizes the holdback for historical claims |
| Credentialing of new providers | How long does adding a provider take? | Drives the ramp for new hires in the buyer's growth plan |
The credentialing matrix. Build one grid with every provider down the side and every payer across the top. Fill each cell with status, effective date and recredentialing date. Two findings recur. A provider billing a payer before credentialing took effect, or under a colleague's number, is a refund finding, not a paperwork gap. A provider who left but is still linked to the group creates confusion in the buyer's revenue model.
Timing and cash flow.
- In an asset deal the buyer may need new enrollments and payer contracts, and collections on new claims can lag after closing. That shows up as a working capital adjustment or an interim billing arrangement. The CMS Medicare provider enrollment page describes the process.
- In an MSO structure, payer contracts often stay with the physician-owned practice, though the contract terms and the transaction details control. Where they do, the buyer tests the practice's contracts as the source of the management fee. Our healthcare deal structures guide covers the model.
- Federal antitrust premerger notice, described on the FTC Premerger Notification Program page, and state healthcare transaction notice laws can set the earliest closing date. Agree a regulatory calendar with the buyer before you put a closing date in the letter of intent. Our healthcare M&A process guide covers sequencing.
Physician Compensation and Referral-Relationship Mapping
Buyers do not start with the law. They start with a map of facts. Whether a given relationship fits a federal or state exception is the legal question covered in the high-risk box below. The seller's job before marketing is to make the facts complete, signed and current.
Facts to gather for every physician.
| Fact | What to produce |
|---|---|
| Pay formula | Base, productivity measure, bonus pool and how each is calculated, with two years of actual payouts |
| Bonus inputs | Every metric that feeds a bonus, and whether any counts ancillary services the physician orders |
| Ownership interests | Stakes in the practice, ASCs, imaging, labs, real estate, equipment and management companies |
| Immediate family ownership | Questionnaire covering spouses, parents, children and siblings in any entity the practice pays or refers to |
| Leases | Every lease with a physician landlord or tenant, all signature pages, renewal history and rent support |
| Directorships and consulting | Agreements, written duties, time logs and rate support |
| Ancillary ordering | Volume and revenue by ordering physician for each ancillary line |
| Outside referral sources | Marketers, liaisons and recruiting vendors, and how each is paid |
| Patient financial policies | Copay waiver and discount policy, with a sample of waived accounts |
The three-column sheet. For every ancillary revenue line, such as imaging, lab and therapy, write down three things. First, the entity that bills it. Second, every physician and family member with a financial relationship to that entity. Third, the signed, current agreement that documents each relationship and its rate support. A blank in the third column is a finding you can fix before a buyer finds it. A quality of earnings team treats revenue behind a blank as revenue at risk.
| Payment to a referring physician | What the buyer wants to see | Fix before marketing |
|---|---|---|
| Medical director stipend | Written duties, time logs, a rate backed by an outside compensation survey or valuation | Re-paper with duties and logs, adjust the rate to the benchmark |
| Consulting fee to a retiring founder | Defined deliverables and evidence they were delivered | Convert to a fixed-scope agreement or end it |
| Rent paid to or by a physician landlord | Signed lease, current terms, market rent support | Commission a rent study and re-sign current terms |
| Free space, staff or equipment | Nothing, ideally | Charge market rates or stop |
| Copay waivers | Written policy and files supporting each waiver | Adopt a policy, retrain staff, audit a sample |
| Marketing or recruiting fees | Flat fees at market rates, not per patient or per test | Restructure away from per-referral pay |
Pay plans are usually rewritten at closing. Have a compensation valuation firm design the post-closing plan before the letter of intent, so the buyer's EBITDA model uses physician pay you have already tested.
Compliance Program Maturity
Buyers use the program's maturity to decide how much of the seller's own work they can rely on. The HHS OIG General Compliance Program Guidance is the reference point most diligence teams use when they score a program.
| Level | What a buyer finds | How it reads in diligence |
|---|---|---|
| 1. Paper only | Template binder, no officer with real time, no audits | Buyer runs its own wider audit, expects more findings and prices control risk |
| 2. Documented | Named compliance officer, annual training, dated policies | Buyer samples to test whether policies are followed |
| 3. Operating | Annual outside coding audit, monthly exclusion screening, hotline log with closed items, refund log | Buyer narrows its sample and relies on the seller's audits |
| 4. Tested and reported | Regular reporting to owners or board, corrective actions tracked to closure, error-rate trends by provider | Supports a cleaner indemnity package and a faster process |
Plan two to three quarters to move from level 1 to level 3. A buyer gives credit for a record of the program operating, and a record takes time to build.
Prior Audits, Refunds and Overpayments
| Item | What the buyer asks for | Effect on price |
|---|---|---|
| Payer audits | Every audit, records request and result in the buyer's look-back period, government and commercial | Shows where payers have already found errors |
| Recoupments and offsets | Open and closed recoupments, appeal status | Open items become escrow or a working capital deduction |
| Refund log | Every refund made, the reason and the payer | Shows the practice finds and returns money on its own |
| Credit balance report | Unresolved patient and payer credit balances by age | Old credit balances are cash owed back and come out of working capital |
| Self-disclosures | Any disclosure made or under consideration | A pending disclosure sets the size of a special escrow |
| Government inquiries | Subpoenas, civil investigative demands, whistleblower suits | The finding most likely to stall or end a deal |
| Payer terminations | Any contract a payer ended for cause | A credibility question in every other contract |
Clear aged credit balances before the quality of earnings work starts. It is the cheapest finding to fix and one of the most common. Once an overpayment is identified, government program rules generally require it to be reported and returned within a set period, so a refund is a deadline obligation and not only an escrow sizing item. Ask your attorney how the timing rules apply to your findings.
How Findings Become Price: Normalization, Escrows, Indemnities and RWI
| Mechanism | Used when | What the seller negotiates |
|---|---|---|
| Price reduction through EBITDA normalization | Revenue is overstated going forward, such as overcoding or a payer contract ending at closing | The normalization amount, and whether it is a recurring item the multiple applies to |
| Special escrow | Historical exposure the buyer can estimate, such as refunds owed | Size, release dates, release on payer closure letters, who keeps the interest |
| Specific indemnity | A known issue with an uncertain amount | Cap, survival period, whether it sits outside the general basket, who controls the response to the payer |
| RWI exclusion | The issue was known before signing, or underwriters see the area as untested | Diligence scope, so the exclusion stays narrow |
| Pre-closing covenant or closing condition | A fixable gap, such as an unsigned lease or an excluded employee | Fix it before signing so it never becomes a condition |
| Earnout | The buyer doubts how durable earnings are | Metric definition, accounting rules, limits on how the buyer runs the business |
| Working capital adjustment | Credit balances, delayed collections after closing | The target level and how credit balances are counted |
Reps and warranties insurance. RWI covers unknown breaches of the seller's representations. Policies generally exclude matters the buyer knew about before signing. A finding disclosed in diligence therefore moves outside the policy, usually into a specific indemnity or a special escrow funded from the seller's proceeds. A clean seller-run coding audit can give the underwriter more to rely on when it sets exclusions.
Earnouts. Buyers tend to use them when they doubt how durable earnings are. In physician deals, buyers often rewrite earnout metrics to leave out ancillary volume the selling physicians order. Model the rewritten metric, not the headline one. Our earnout value calculator runs the math, and our LOI and term sheet red flags checklist flags volume-linked terms before you sign.
How buyers handle each type of finding.
| Type of finding | Typical buyer response | Seller's best move |
|---|---|---|
| Paperwork gap with no money at stake (unsigned lease renewal at market rent, missing duties schedule) | Pre-closing covenant | Fix it before marketing |
| Coding pattern that inflated revenue | EBITDA normalization, price cut at the multiple, refund holdback | Run your own audit and present normalized numbers first |
| Pay plan that rewards ordered ancillaries | Redesigned post-closing pay, sometimes a price adjustment if physician pay rises | Have the plan redesigned and valued before the LOI |
| Provider billing before credentialing took effect | Refund holdback, closing deliverable to clean up | Correct, refund and document before marketing |
| Aged credit balances | Working capital deduction | Resolve and refund before the QoE starts |
| Excluded individual on payroll | Often a closing condition or specific indemnity, depending on the facts and deal terms | Remove, resolve and document before marketing |
| Weak compliance program | Wider sampling, lower multiple, covenants | Build a record of operating at level 3 |
| Breach history or weak security controls | Remediation covenant, cyber insurance requirement, specific indemnity | Commission a security assessment and close the gaps |
| Pending investigation or whistleblower suit | Large specific indemnity, large escrow, or no deal | Disclose early with a quantified analysis. Surprises cost more than known issues |
Worked Example: How a Coding Error Rate Changes Value
Hypothetical. The practice and every figure below are invented to show the mechanics. All arithmetic is ours. All values are enterprise value, before debt, transaction fees, taxes and rollover.
| Assumption | Value |
|---|---|
| Annual net collections | $10.0 million |
| Evaluation and management (E/M) revenue, the population the sample covers | $4.0 million |
| Adjusted EBITDA before any coding finding | $2.5 million |
| Valuation multiple | 9.0x, an assumption for the example and not a market quote |
| Cost effect of correcting codes | None. Overbilled revenue falls straight to EBITDA |
| Holdback for historical claims | Three years of overbilling, chosen only to make the arithmetic easy to follow. It is not a typical or recommended term. Buyers may size exposure on longer payer and legal look-back periods, which your attorney can explain |
A private practice's multiple depends on its size, payer mix and growth, which is why the example uses an assumed figure rather than a market quote.
Step 1: the sample. An outside coder reviews 200 E/M claims that were paid a total of $30,000. Twenty-six claims are overcoded, a claim error rate of 13%. The overpaid dollars on those claims total $1,800, a dollar error rate of 6.0% ($1,800 ÷ $30,000).
Step 2: extrapolate. The buyer applies the 6.0% dollar error rate to the $4.0 million of E/M revenue the sample represents. That is $240,000 of overstated revenue a year. It does not apply the rate to the full $10.0 million, because the sample did not test the other lines. In practice, sample size, stratification by provider and code, and payer mix all affect how reliable an extrapolation is, and a seller can challenge one built on a weak sample. This example ignores sampling error. A 200-claim sample leaves a margin of error around the $240,000 figure, so a seller can ask the buyer to show its confidence range and how the sample was stratified.
Step 3: value at different error rates.
| Dollar error rate | Overstated E/M revenue a year | Normalized EBITDA | Value at 9.0x | Value lost | Three-year holdback |
|---|---|---|---|---|---|
| 0% | $0 | $2.50M | $22.50M | $0 | $0 |
| 2% | $80,000 | $2.42M | $21.78M | $0.72M | $240,000 |
| 4% | $160,000 | $2.34M | $21.06M | $1.44M | $480,000 |
| 6% | $240,000 | $2.26M | $20.34M | $2.16M | $720,000 |
| 10% | $400,000 | $2.10M | $18.90M | $3.60M | $1.20M |
At a 9.0x multiple, each dollar of annual overbilling removes $9 of enterprise value and ties up another $3 in holdback.
The lost value is not avoidable. It is revenue the practice should not have billed. What the seller controls is the multiple, the escrow and the retrade.
Step 4: who finds it first.
| Path A: seller finds it 12 months out | Path B: buyer finds it after the LOI | |
|---|---|---|
| Value in the letter of intent | $20.34M, on corrected EBITDA of $2.26M | $22.50M, on unadjusted EBITDA of $2.50M |
| Multiple after diligence | 9.0x | 8.5x, assuming the buyer trims 0.5x for weak billing controls |
| Final value | $20.34M | $19.21M ($2.26M × 8.5) |
| Refunds of $720,000 | Paid by the seller before marketing | Funded from a special escrow at closing |
| Enterprise value less refunds (rough proxy, not seller proceeds) | $19.62M | $18.49M |
| Retrade from the LOI | None | $3.29M |
Under these assumptions, Path A leaves the seller $1.13 million better off ($19.62M less $18.49M), which equals the 0.5x multiple cut on $2.26 million of EBITDA. This is an illustration, not an expected or typical sale outcome. It assumes the buyer accepts the seller's corrected EBITDA at the full 9.0x with no retrade, and in practice a buyer may still trim price in Path A. The gap also moves with the assumed 0.5x multiple cut and three-year holdback, and the enterprise value less refunds row nets a seller cash payment against enterprise value. It is not a measure of what the seller takes home, which also depends on debt, fees, taxes and rollover, so treat it only as a rough comparison of the two paths. Path A also avoids the harder costs. There is no $3.29 million retrade late in the process, the refunds are closed before the buyer arrives, and no escrow stays open waiting on payer closure letters.
Pre-Sale Self-Audit Timeline
This sequence is our recommendation for owners planning a sale or recapitalization. Commission the reviews through your healthcare attorney so the findings can stay privileged until you decide what to do with them.
| When | Workstream | Output |
|---|---|---|
| 12 to 18 months out | Run an internal review across all six workstreams | Issues list ranked by dollar exposure |
| 12 to 15 months out | Outside coding audit and exclusion screening | Claim and dollar error rates by provider and code, screening log |
| 9 to 12 months out | Fix paperwork: leases, directorships, consulting agreements, waiver policy | Signed, current agreements with rate support |
| 9 to 12 months out | Build the credentialing matrix and clear gaps | Provider-by-payer grid with effective dates |
| 9 to 12 months out | Resolve aged credit balances and quantify refunds | Refund log and a decision on each open item |
| 6 to 9 months out | Value physician pay and design the post-closing plan | Valuation support and a bonus model |
| 6 to 9 months out | Re-sample coding to show improvement, run a security assessment | Trend data, remediation plan |
| 3 to 6 months out | Sell-side quality of earnings that reflects coding and pay normalizations | Numbers a buyer can confirm |
| 3 to 6 months out | Build the data room and the three-column sheet | File indexed to the buyer's request list |
| Before the LOI | Map transaction notice and structure questions for every state in the footprint | Regulatory calendar the buyer agrees to |
Our guide to preparing a healthcare company for sale covers the broader readiness process.
Compliance Due Diligence Document List
| Category | Documents |
|---|---|
| Billing and coding | Claims data by provider and code for 12 to 36 months, internal and outside coding audit reports, corrective action records, coding policies and templates |
| Payer contracts | Every contract and amendment, fee schedules, change-of-control and termination clauses, payer correspondence |
| Credentialing and enrollment | Provider-by-payer credentialing matrix, Medicare and Medicaid enrollment records, NPI list |
| Prior audits and refunds | Audit letters and results, recoupment notices, appeals, refund log, credit balance report, any self-disclosures |
| Physician relationships | Employment agreements, pay formulas, two years of bonus calculations, directorship and consulting agreements with time logs |
| Ownership | Capitalization table, org chart naming the billing entity for each line, family ownership questionnaires |
| Real estate | Every lease with all signature pages, renewal history, rent studies for physician-owned property |
| Ancillary services | Revenue by line, payer and ordering physician, staffing and supervision schedules, lab certificates |
| Compliance program | Compliance plan, officer job description, training records, hotline log, audit calendar, exclusion screening log |
| Privacy and security | Privacy and security risk assessment, policies, business associate agreements, breach log, cyber insurance policy |
| Licensing | Facility licenses, DEA registrations, physician license status in every state, disciplinary history, malpractice coverage and tail arrangements |
Our healthcare data room checklist shows where each document belongs.
Whom to Hire
| Adviser | Role | When to engage |
|---|---|---|
| Healthcare regulatory and M&A attorneys | Direct privileged reviews, structure, purchase agreement, escrow and indemnity terms | First, 12 to 18 months out |
| Certified coding auditor | Independent coding sample and re-sample | 12 to 15 months out |
| Credentialing specialist | Builds and cleans the provider-by-payer matrix | 9 to 12 months out |
| Compensation valuation firm | Rate support for physician pay, directorships and leases | 6 to 9 months out |
| Security assessor | Privacy risk assessment and cybersecurity review | 6 to 9 months out, earlier for health IT |
| Quality of earnings accountant | Sell-side QoE that reflects coding and pay normalizations | 3 to 6 months out |
| RWI broker | Advises on insurability and likely exclusions | During buyer selection |
If you engage a sell-side banker, look up the firm and the individual on FINRA BrokerCheck, a free record of registration and disclosure history.
Questions Investors Should Ask a Healthcare Platform About Compliance
Family offices and other investors backing a platform, or taking a minority stake, carry the same exposure through their equity. Ask these before committing capital:
- What were the dollar error rates in the most recent outside coding audit, by site and by provider?
- How does the platform screen each add-on before closing, and who signs off?
- Which payer audits, recoupments and refunds are open, and how large are they?
- What share of revenue comes from ancillary lines, and is the three-column sheet complete for each?
- How were physician pay plans valued, and when was that last refreshed?
- Can we see the credentialing matrix and the exclusion screening log, not a summary?
- At what maturity level would an outside reviewer score the compliance program?
- Does the platform carry RWI on add-ons, and how are known issues handled outside the policy?
- What has the platform raised before? Form D notices on SEC EDGAR full-text search show private offerings a company has filed.
Our guide to private equity physician roll-ups covers platform economics. If you are selling a physician practice, run the same questions in reverse on any buyer that offers rollover equity.
High-risk area: Physician referrals, kickbacks and practice ownership
Federal rules limit how referring physicians can be paid and what they can own, and labs and certain other services face added federal rules. Many states add their own anti-kickback and self-referral laws, along with corporate practice of medicine doctrines that limit who can own or control a medical practice. How these rules apply depends on your state, your deal structure and your facts, so this page stays at a high level. Engage a healthcare attorney, and a securities attorney if you will hold rollover equity, and bring these questions.
Questions to ask your attorney
1. Does each ancillary line we bill for, such as imaging, lab and therapy, still fit a self-referral exception after closing, given the new staffing, pay plan and rollover equity?
- Why ask: Ancillary lines are often the highest-margin revenue in the practice, and a roll-up changes the facts an exception rests on.
- What can go wrong: A structure that fit before closing may stop fitting after it, which can put that revenue and the related claims at risk.
2. Are post-closing physician pay, bonuses, directorship fees and consulting fees supported at fair market value, and is any of it linked to referrals?
- Why ask: Buyers and regulators look closely at how referring physicians are paid, and pay plans are usually rewritten at closing.
- What can go wrong: Pay that looks above market or tied to referrals can draw scrutiny, whistleblower complaints and large settlements, even years later.
- Example: In December 2023 the U.S. Department of Justice announced that Community Health Network, an Indianapolis health system, agreed to pay $345 million to resolve allegations that it paid recruited specialists above fair market value and paid bonuses tied to referrals, then billed Medicare for the referred services. The case began with a whistleblower complaint filed in 2014 by the system's former CFO and COO. The system denied the allegations and entered a five-year Corporate Integrity Agreement. U.S. Department of Justice
3. Could the purchase price, earnout, leaseback or any side agreement be read as payment for future referrals?
- Why ask: Sellers who stay on and keep referring sit on both sides of the deal, so the reason for every dollar needs to be documented.
- What can go wrong: An earnout or side payment that tracks volume the seller orders may need to be rewritten late in the process, which can cut its value.
4. Does the MSO structure and management fee formula work in every state where we operate, and how would it hold up if a state changed its rules?
- Why ask: The fee formula sets how much practice profit reaches the investor, and rollover equity is only as durable as the structure behind it.
- What can go wrong: A rule change can force a restructuring after closing and reduce the value of rollover equity.
- How states have handled it: Some states have recently tightened limits on how management services organizations can own and control the practices they manage, and those laws continue to be amended. This can affect deal timing and structure, so raise it with your own attorney.
5. Do any historical arrangements or coding findings create repayment exposure, and should we consider a self-disclosure before we go to market?
- Why ask: The disclosure and refund decision shapes the escrow and indemnity a buyer will ask for.
- What can go wrong: An issue the buyer finds on its own can lead to a price cut, a large special escrow or a lost deal.
6. Which federal and state transaction notice or review filings may apply to this deal, and how do they affect a realistic closing date?
- Why ask: A growing number of states have passed healthcare transaction notice or review laws, and the rules keep changing.
- What can go wrong: A missed or late filing can push closing back and put the closing date in the letter of intent at risk.
7. Does our lab revenue raise questions beyond the main kickback and self-referral analysis, including for commercially insured patients?
- Why ask: Lab lines can draw closer review, and payer mix may not limit the questions the way owners expect.
- What can go wrong: Lab revenue the buyer counted on can be discounted or carved out late in diligence.
Other topics to raise with your attorney
- Whether licenses, Medicare and Medicaid enrollments and payer contracts transfer, and what a change of ownership involves
- Whether the compliance and privacy reps in the purchase agreement cover state law as well as federal law
- How copay waiver policies, exclusion screening and marketing arrangements should be documented before marketing
- Whether the local market share of the combined platform could draw antitrust attention
- How rollover equity terms, transfer limits and buy-back rights work if you leave the practice
Questions Owners and Investors Ask About Compliance Due Diligence
What do buyers test first in healthcare compliance due diligence?
They start with billing and coding accuracy and the physician compensation and referral map, because both change the earnings the buyer will pay a multiple on. Next come payer contracts and credentialing, the maturity of the compliance program, prior audits and refunds, and privacy and data security. A platform buying add-ons often sends a long request list early in the process, so an organized seller can answer much of it before the buyer's team arrives.
How does a coding error rate change my sale price?
The buyer applies the dollar error rate from its chart sample to the revenue that sample represents, removes the overstated amount from adjusted EBITDA and applies the multiple to it. In our worked example, a 6.0% dollar error rate on $4.0 million of evaluation and management revenue removes $240,000 of EBITDA. At an assumed 9.0x multiple that is $2.16 million of enterprise value. A holdback sized at three years of overbilling ties up another $720,000.
Does reps and warranties insurance cover compliance problems?
It covers unknown breaches of the seller's representations, subject to the policy terms. Policies generally exclude matters the buyer knew about before signing. Once a compliance finding is disclosed in diligence it moves outside the policy, usually into a specific indemnity or a special escrow funded from the seller's proceeds. A seller-run coding audit can also give an RWI underwriter more to rely on when it sets exclusions.
Will a compliance finding in diligence kill my deal?
Usually not. Most findings move money rather than end deals. Overstated revenue comes off the price at the multiple, estimated refunds go into a special escrow, and uncertain exposure goes into a specific indemnity. The findings that do end deals are the ones a buyer cannot size or fix, such as a pending investigation or a structure that cannot work in a key state. A buyer that finds an issue on its own tends to widen its sample and trim its multiple.
When should I start a pre-sale compliance self-audit?
Start 12 to 18 months before you plan to go to market. That leaves time to run an outside coding review, re-paper physician agreements, clean up credentialing, resolve refunds and build a record of the compliance program operating. A buyer gives little credit to fixes made the month before the data room opens, because there is no track record behind them.
What should investors ask a healthcare platform about compliance?
Ask for the platform's most recent outside coding audit results by site, how it re-screens each add-on before closing, which payer audits and refunds are open, how physician pay plans were valued, and whether it carries reps and warranties insurance on add-ons and how it handles known issues outside the policy. Ask to see the credentialing matrix and the exclusion screening log, not a summary of them.
Sources
- CMS, National Health Expenditure Fact Sheet (2024 data)
- Private Equity Stakeholder Project, Private Equity Healthcare Deals: 2025 in Review (PitchBook and LevinPro HC data)
- Becker's ASC Review, The outpatient specialties that dominated 2025 deal activity (reporting PESP data)
- FOCUS Investment Banking, Dermatology Practice Valuation: 2026 Benchmarks
- HHS Office of Inspector General, Exclusions Program
- HHS Office of Inspector General, General Compliance Program Guidance
- CMS, Medicare Provider and Supplier Enrollment
- Federal Trade Commission, Premerger Notification Program
- FINRA BrokerCheck
- SEC EDGAR Full-Text Search
- U.S. Department of Justice, Community Health Network Agrees to Pay $345 Million to Settle Allegations, December 2023